196 related articles for article (PubMed ID: 24491089)
1. Antigen-specific therapy against type 1 diabetes: mechanisms and perspectives.
Wan X; Zaghouani H
Immunotherapy; 2014; 6(2):155-64. PubMed ID: 24491089
[TBL] [Abstract][Full Text] [Related]
2. Parameters influencing antigen-specific immunotherapy for type 1 diabetes.
Wang B; Tisch R
Immunol Res; 2008; 41(3):175-87. PubMed ID: 18543112
[TBL] [Abstract][Full Text] [Related]
3. Analysis of antigen specific T cells in diabetes - Lessons from pre-clinical studies and early clinical trials.
Krishnamurthy B; Selck C; Chee J; Jhala G; Kay TW
J Autoimmun; 2016 Jul; 71():35-43. PubMed ID: 27083395
[TBL] [Abstract][Full Text] [Related]
4. Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice.
Lo J; Xia CQ; Peng R; Clare-Salzler MJ
J Immunol Res; 2018; 2018():5463879. PubMed ID: 29651443
[TBL] [Abstract][Full Text] [Related]
5. CD11a/ICAM-1 blockade combined with IL-2 targeting therapy causes a paradoxical acceleration of type 1 diabetes.
Brenu EW; Bartley TJ; Wright CM; Hamilton-Williams EE
Immunol Cell Biol; 2017 Oct; 95(9):803-813. PubMed ID: 28611472
[TBL] [Abstract][Full Text] [Related]
6. Revealing the specificity of regulatory T cells in murine autoimmune diabetes.
Spence A; Purtha W; Tam J; Dong S; Kim Y; Ju CH; Sterling T; Nakayama M; Robinson WH; Bluestone JA; Anderson MS; Tang Q
Proc Natl Acad Sci U S A; 2018 May; 115(20):5265-5270. PubMed ID: 29712852
[TBL] [Abstract][Full Text] [Related]
7. Role of regulatory T cells for the treatment of type 1 diabetes mellitus.
Jaeckel E; Mpofu N; Saal N; Manns MP
Horm Metab Res; 2008 Feb; 40(2):126-36. PubMed ID: 18283631
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
9. Combining anti-IL-7Rα antibodies with autoantigen-specific immunotherapy enhances non-specific cytokine production but fails to prevent Type 1 Diabetes.
Vazquez-Mateo C; Collins J; Goldberg SJ; Lawson M; Hernandez-Escalante J; Dooms H
PLoS One; 2019; 14(3):e0214379. PubMed ID: 30908554
[TBL] [Abstract][Full Text] [Related]
10. Generation of human islet-specific regulatory T cells by TCR gene transfer.
Hull CM; Nickolay LE; Estorninho M; Richardson MW; Riley JL; Peakman M; Maher J; Tree TI
J Autoimmun; 2017 May; 79():63-73. PubMed ID: 28117148
[TBL] [Abstract][Full Text] [Related]
11. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.
Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW
J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333
[TBL] [Abstract][Full Text] [Related]
12. Resuscitating adaptive Tregs with combination therapies?
Bresson D; von Herrath M
Novartis Found Symp; 2008; 292():50-60; discussion 60-7, 122-9, 202-3. PubMed ID: 19203092
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for the prevention and treatment of type 1 diabetes.
Goudy KS; Tisch R
Int Rev Immunol; 2005; 24(5-6):307-26. PubMed ID: 16318984
[TBL] [Abstract][Full Text] [Related]
15. Protective response against type 1 diabetes in nonobese diabetic mice after coimmunization with insulin and DNA encoding proinsulin.
Zhang W; Jin H; Hu Y; Yu Y; Li X; Ding Z; Kang Y; Wang B
Hum Gene Ther; 2010 Feb; 21(2):171-8. PubMed ID: 19788384
[TBL] [Abstract][Full Text] [Related]
16. Combination Therapy Using IL-2/IL-2 Monoclonal Antibody Complexes, Rapamycin, and Islet Autoantigen Peptides Increases Regulatory T Cell Frequency and Protects against Spontaneous and Induced Type 1 Diabetes in Nonobese Diabetic Mice.
Manirarora JN; Wei CH
J Immunol; 2015 Dec; 195(11):5203-14. PubMed ID: 26482409
[TBL] [Abstract][Full Text] [Related]
17. T-lymphocyte recognition of beta cells in type 1 diabetes: clinical perspectives.
Boitard C
Diabetes Metab; 2013 Dec; 39(6):459-66. PubMed ID: 24139825
[TBL] [Abstract][Full Text] [Related]
18. Continuum model of T-cell avidity: Understanding autoreactive and regulatory T-cell responses in type 1 diabetes.
Jaberi-Douraki M; Pietropaolo M; Khadra A
J Theor Biol; 2015 Oct; 383():93-105. PubMed ID: 26271890
[TBL] [Abstract][Full Text] [Related]
19. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
[TBL] [Abstract][Full Text] [Related]
20. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
